Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richard Bittner AG is an Austrian pharmaceutical company specializing in the development, production, and marketing of natural and homeopathic medicines. Founded in 1954 and headquartered in Feldkirchen, the company is well-known for its established brands such as Aflubin, Gentos, and Bittner Balsam, which target a variety of indications including respiratory health, urology, and general wellness. The company operates as a subsidiary within the Perrigo Group, following its acquisition via Omega Pharma. Richard Bittner maintains a strong commercial presence in Central and Eastern Europe, focusing on evidence-based natural remedies and over-the-counter (OTC) healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DHU-Bittner.